A total of thirty healthy volunteers (15 F, 15 M) were
recruited for the trial from Melbourne, Australia.The
primary inclusion criterion was a systolic blood pressure
(SBP) of greater than 120 mmHg at the time of administering
the first treatment.Subjects who were pregnant/
lactating, on blood pressure medication or had been
diagnosed with diabetes mellitus were excluded from
participating.